InsidersTradesSigma
Follow the CalciMedica, Inc. /DE/ share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €10.9m. The latest transaction was disclosed on 22 March 2023 (Attribution). Among the most active insiders: Roberts Eric W. All data is accessible without an account.
Analysts rate CalciMedica, Inc. /DE/ Strong Buy (bullish), based on 2 analysts. Average price target: US$10.50.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
CalciMedica, Inc. is a biotechnology company focused on developing treatments for diseases related to calcium regulation. It is listed on NASDAQ under the ticker XNAS.